This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Injectable Drug Delivery Market

Market Insights on Injectable Drug Delivery covering sales outlook, demand forecast & up-to-date key trends

Injectable Drug Delivery Market By Product (Self-Injectors, Needle-Free Injectors, Auto-Injectors), Usage (Disposable Injectors, Reusable Injectors), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce) & Region - Forecast 2022 - 2028

Injectable Drug Delivery Market Snapshot (2022-2028)

[232 Pages Report] Sales in the global Injectable Drug Delivery Market are slated to top US$ 41.5 Bn in 2022, projects Future Market Insights (FMI). Expanding at a healthy 8.9% CAGR, the market size is projected to total US$ 69.13 Bn by 2028.

The increasing adoption of self-administrated drugs that require regular doses, favored by cost-effectiveness and reduced hospital visits is boosting sales in the market. In addition to this, the growing preference for smart devices that can track doses and facilitate patient compliance is expected to remain one of the chief drivers of the injectable drug delivery market over the assessment period.

Attribute

Details

Estimated Injectable Drug Delivery Market Size 2022

US$ 41.5 Bn

Injectable Drug Delivery Market Value-based CAGR (2022-2028)

~8.9%

Projected Injectable Drug Delivery Market Size in 2028

US$ 69.13 Bn

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

8.57%

H1, 2022 Projected

8.78%

H1, 2022 Outlook

7.68%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 110 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 89 ↓

According to Future Market Insights analysis, the global injectable drug delivery market expects to drop by 89 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. The requirement for consistency and simplicity of administration for pharmacological combinations is a significant technological problem in the market associated with the observed drop in the BPS values.

The use of injectables is accompanied with a number of clinical difficulties. In comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 110 BPS.

In addition to managing adverse drug reactions without reserving the possibility to promptly withdraw therapy, these difficulties also include concerns about the possibility of injection site reactions (which may be made worse by the existing requirement for large injection volumes) and the possibility of viral resistance developing during extended periods of sub-therapeutic exposure following therapy discontinuation.

The increasing adoption of self-administrated drugs that require regular doses, favoured by cost-effectiveness and reduced hospital visits is boosting sales in the market. In addition to this, the growing preference for smart devices that can track doses and facilitate patient compliance is expected to remain one of the chief drivers of the injectable drug delivery market over the assessment period.

2022-2028 Injectable Drug Delivery Market Outlook in Comparison to Growth Registered in 2014-2021

Demand for injectable drug delivery is poised to grow at a robust 8.9% CAGR, in comparison with the 7.2% CAGR registered between 2014 and 2021.

Burgeoning demand for cost-effective and quality drug injectors is encouraging product development in the market. The COVID-19 outbreak has spurred awareness regarding hygienic and safe injectors, which is compelling several manufacturers to launch sterile injectables, auto-injectors drug delivery devices, and wearables.

Injectable Drug Delivery Market Download Report Brochure

Injectable devices primarily find applications in the treatment of diabetes. As per the World Health Organization (WHO), diabetes incidence rose from 108 million in 1980 to 422 million in 2014. In 2019, diabetes was the ninth leading cause of death, with approximately 1.5 million deaths directly caused by the disease.

Diabetes patients are prescribed insulin which requires regular administration. On the flip side, the risk of needle-stick injuries is a common concern. Hence, injectable drug delivery and wearable insulin pumps are emerging as the most preferred options for diabetic patients. These devices have thin needles that eliminate the risk of injuries.

The introduction of smart wearables and devices that track time and dosage will continue boosting sales in the injectable drug delivery technology market. These devices send timely reminders and offer automatic dose adjustment to facilitate treatment adherence and compliance.

How is the Development of Novel Drugs Fast-tracking Growth in Injectable Drug Delivery Market?

Rinsing incidence of chronic ailments and other life-threatening diseases is underpinning the need for novel and effective drugs in various therapeutic areas. The convenience and at-home accessibility offered by injectable drugs are compelling manufacturers and pharmaceutical companies to develop efficient devices for the treatment of various ailments.

For instance, the use of injectable contraceptives has been increasing considerably since the last few years. This can be attributed to the high efficacy and convenience offered by these injectables. These contraceptives are not required to be taken daily, they can be administered once a month or three months. Due to this factor, sales of these injectable drug delivery devices are gaining traction.

Coupled with this, timely drug approvals by regulatory bodies such as the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) will widen the scope for the adoption of injectable drug delivery.

In January 2021, the FDA announced the approval of Cabenuva (cabotegravir and riprivine) in injectable formulation as a complete treatment regimen for human immunodeficiency virus type-1 (HIV-1) infection in adults. This is the first FDA-approved injectable which requires to be administered once a month.

Collaborations among pharmaceutical companions and research organizations for drug research and development are also expected to bode well for the market. In February 2021, for instance, Phillips Medisize and Subcuject announced a collaboration to launch a new wearable bolus injector.

Its simple osmotic drive offers low-cost bolus injection technology, allowing injectable wearable devices to be applied in a broader range of drugs. The new product meets the growing demand for large volume injectors to reduce injection frequency, and supports at-home medication delivery. Backed by such developments, the needle-free injectors market is expected to witness considerable growth in the forthcoming years.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

How is the U.S. Injectable Drug Delivery Market Faring?

“Increasing Cases of Cancer to Boost the Development of Injectable Drug Delivery Devices”

The rising incidence of chronic diseases, such as cancer and diabetes in the U.S. is anticipated to spur the demand for smart and effective drug delivery options for better treatment. This is likely to usher new product developments by manufacturers and research institutes in the country, thereby boosting the growth. As per FMI, the North America market is projected to account for 33.4% of the total market share in 2021.

As per the National Cancer Institute, an estimated 1,806,590 new cases of cancer were diagnosed in the U.S. in 2020. This is expected to propel the development of novel injectable drug delivery devices in the oncology sector, thereby augmenting the growth of the U.S. market.

The presence of a robust healthcare sector, public healthcare reimbursements, and delivery of medical devices and medications through online channels will also continue to augment the U.S. market in the forthcoming years.

What is the U.K. Injectable Drug Delivery Market Outlook?

“Technological Development of Auto-injectors Drug Delivery to Propel the Growth”

Growing demand for smart and effective wearables for patient care in the U.K. is expected to boost sales over the assessment period. The Europe injectable drug delivery market is forecast to command 29.4% of the global market share in 2021, finds FMI.

Ongoing technological advancements in self-injection devices, especially in auto-injectors drug delivery and wearables for the administration of large volume and high-viscosity drugs are creating lucrative opportunities for market players in the U.K. This is expected to continue fueling the growth of the market.

Apart from that, the introduction of connective technology, such as Artificial Intelligence (AI) and Bluetooth in smart wearables is expected to bode well for the U.K. market. These devices send alerts regarding dosage timings and track dosages, thereby making them an effective drug delivery method for the elderly.

Why is the China Injectable Drug Delivery Market Witnessing High Demand?

“Availability of Low-cost Raw Materials to Push the Sales of Self-injection Devices”

China is expected to account for a dominant share in the East Asia market over the forecast period. As per FMI, East Asia is expected to account for 14.4% of the total market share in 2021.

Increasing investments in the expansion of the healthcare sector by government bodies in China are creating a conducive environment for novel drug development in the country. Various global pharmaceutical companies are aiming to expand their footprints in China, owing to the wide availability of low-cost raw materials and growing demand for branded drugs, as well as self-injection devices.

Further, the expansion of the biologics sector will continue pushing sales in the market. Increasing production of vaccines, insulin, gene and cellular therapies, growth inhibitors, and cytokines in the biologics sector is spurring the demand for effective drug delivery options, which in turn, is augmenting the growth of the market in China.

Category-wise Insights

Why are Needle-free Injectors Highly Sought-After?

“Need to Eliminate Possible Injuries and Pain to Propel the Needle-free Injectors Market”

Based on product type, the demand for needle-free injectors is expected to gain traction in the forthcoming years, as per the report. Needle-free injectors eliminate pain and possible injuries as they drive drugs through the patients’ skin using any of the forces such as Shock Wave, Lorenz, and electrophoresis, which nullifies the need for hypodermic needles.

Needle-free Injection Technology (NFIT) is a beneficial development in the pharmaceutical industry as it is highly useful in mass vaccination and immunization programs, thereby eliminating the chances of needle injuries and multiple use of single needle. Backed by these factors, the needle-free injectors market is anticipated to grow at a fast pace over the forecast period.

Why is the Demand for Reusable Injectors Rising?

“Ability of Auto-injectors Drug Delivery Devices to Surge Therapeutic Value Will Boost Demand for Reusable Injectors”

In terms of usage, sales of reusable injectors are projected to gain traction over the assessment period. Biological and biosimilar drugs are fragile proteins, which require administration through injection. Auto-injectors drug delivery devices increases the therapeutic value of these drugs, which is propelling the sales of reusable injectors.

When these drugs are prescribed to patients with chronic diseases, such as growth hormone disorders, multiple sclerosis, and diabetes, reusable injectors are a sensible option for administering daily doses. These injectors improve safety and accessibility while reducing the volume of storage and waste footprint, and are significantly more cost-effective.

Which is the Most Preferred Distribution Channel?

“Hospital Pharmacies to Exhibit High Sales of Pen-injectors Drug Delivery Products”

Demand in the hospital pharmacies segment is projected to gain momentum over the forecast period, owing to the assistance offered by healthcare providers regarding the usage of injectables. Besides this, wide availability of products, such as pen-injectors drug delivery devices at these pharmacies will continue boosting sales in this segment.

However, the e-commerce segment is projected to expand at a considerable pace. This growth is attributable to the high emphasis on safety and no-contact delivery induced by the COVID-19 pandemic. The surging availability of drugs and medical equipment on online retail channels and timely delivery offered by them is a chief factor driving sales in this segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competition Landscape

Leading players operating in the global injectable drug delivery market are focusing on research and development activities to launch innovative products in the market. In addition to this, these players are investing in mergers, acquisitions, and collaborations to gain a competitive edge in the injectable drug delivery technology market. For instance:

  • In September 2021, Antares Pharma, Inc. announced that it has begun the phase 1 study for ATRS-1902 for adrenal crisis rescue. The program supports a proposed indication for treatment of acute adrenal insufficiency in adults and adolescents, using a new proprietary auto-injector platform to deliver a liquid formulation of hydrocortisone.
  • In November 2021, Becton, Dickinson and Company launched the BD Ultrasafe Plus 2.25 ml Passive Needle Guard for use in drug-device combination products. When combined with Glass Prefillable Syringe, the new system enables delivery of biologic solutions of different volumes up to 2ml and viscosities of up to 30 cP.

Injectable Drug Delivery Market Report Scope

Future Market Insights’ latest report sheds light into the factors that are driving sales of injectable drug delivery products and devices. For instance, how are increasing prevalence of diabetes and the rising adoption of injectable contraceptives augmenting the demand for injectable drug delivery technology, have been thoroughly analyzed.

Future Market Insights has conducted meticulous research to unveil major investment pockets within the injectable drug delivery industry. It brings leading distribution channels among hospital pharmacies, retail pharmacies, and e-commerce under the spotlight.

The report highlights why needle-free injectors are scoring high in terms of consumer preference. Apart from that, it presents exhaustive research into various factors pushing reusable injectors to the forefront.

The report further offers a geographic assessment that consists of in-depth information about latest trends that are accelerating both developed and developing economies. It identifies why the rising incidence of cancer in the U.S. is catapulting North America injectable drug delivery market to the dominant position.

Besides, the report delivers a few chapters on recent industry developments in terms of injectable drug delivery innovations. The overall impact of these developments have been scrutinized to offer a unique outlook for 2022-2028.

The injectable drug delivery market analysis includes:

  • A 6-year realistic outlook of injectable drug delivery sales forecast across 7 verticals
  • Insights into current trends, growth drivers, and new opportunities
  • Go-to-market strategies and elaborate information to identify customers for potential opportunities
  • Insights into geographic opportunities that have the highest market potential and unmet needs
  • Statistics and graphs to evaluate new revenue sources and target customers

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2014-2021

Market Analysis

Units for Volume and US$ Mn for Value

Report Coverage

Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Key Segments Covered

  • Product Type
    • Self-Injectors
    • Needle-free Injectors
    • Auto-Injectors
  • Usage
    • Disposable Injectors
    • Reusable Injectors
  • Distribution Channels
    • Hospital Pharmacies
    • Retail Pharmacies
    • E-commerce

Key Regions Covered

  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Nordic
    • Russia
    • Poland
  • East Asia
    • China
    • India
    • Japan
  • South Asia
    • Thailand
    • Indonesia
  • Oceania
    • Australia
    • New Zealand
  • MEA
    • GCC Countries
    • North Africa
    • South Africa

Key Companies Profiled

Amgen Inc., Antares Pharma Inc., Becton, Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, Medtronic plc, Mylan N.V., SHL Group, West Pharmaceutical Services, and Ypsomed.

Customization & Pricing

Available upon Request

Injectable Drug Delivery Market by Category

Product Type:

  • Self-Injectors
  • Needle-free Injectors
  • Auto-Injectors

Usage:

  • Disposable Injectors
  • Reusable Injectors

Distribution Channels:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

The global injectable drug delivery market is expected to reach a valuation of US$ 41,1501.1 Mn in 2022.

The global injectable drug delivery market grew at a healthy 7.2% CAGR between 2014 and 2021.

Increasing demand for self-administrated drugs, along with growing demand for smart wearables are chief factors driving sales of injectable drug delivery.

Amgen Inc., Antares Pharma Inc., Becton, Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, Medtronic plc, Mylan N.V., SHL Group, West Pharmaceutical Services, and Ypsomed are some of the leading players operating in the global injectable drug delivery market.

North America injectable drug delivery market is projected to account for 33.4% of the total market share in 2021.

The injectable drug delivery market in Europe is anticipated to account for 29.4% of the total market share over the assessment period.

Table of Content

1. Executive Summary

   1.1. Market Overview

   1.2. Market Analysis

   1.3. FMI Analysis and Recommendations

   1.4. Wheel of Fortune

2. Market Introduction

   2.1. Market Taxonomy

   2.2. Market Definition

3. Market Opportunity Analysis

   3.1. Macro-Economic Factors

   3.2. Opportunity Analysis

4. Market Background

   4.1. Recent Developments

   4.2. Market Dynamics

      4.2.1. Drivers

      4.2.2. Restraints

5. Global Economic Outlook

   5.1. Gross Domestic Product by Region & Country, 2006 – 2021

6. Key Inclusions

   6.1. Key Manufacturer List

   6.2. Key Developments

   6.3. PEST Analysis

7. North America Market Analysis 2014–2021 and Forecast 2022–2028

   7.1. Introduction

   7.2. Regional Market Trends

   7.3. Historical Market Size (US$ Mn) Analysis By Country, 2014–2021

      7.3.1. U.S.

      7.3.2. Canada

   7.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      7.5.1. Self-Injectors

      7.5.2. Needle free Injectors

         7.5.2.1. Pre Filled Needle free injectors

         7.5.2.2. Fill-Able Needle Free Injectors

      7.5.3. Auto Injectors

   7.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   7.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      7.7.2. Reusable Injectors

      7.7.2. Reusable Injectors

   7.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      7.9.1. Retail Pharmacies

      7.9.2. Hospital pharmacies

      7.9.3. E-Commerce

   7.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   7.11. Drivers and Restraints: Impact Analysis

   7.12. Market Attractiveness Analysis

      7.12.1. By Country

      7.12.2. By Product

      7.12.3. By Usage

      7.12.4. By Distribution Channel

   7.13.Drivers and Restraints – Impact Analysis

8. Eastern Europe Market Analysis 2014–2021 and Forecast 2022–2028

   8.1. Introduction

   8.2. Regional Market Trends

   8.3. Historical Market Size (US$ Mn) By Country, 2014–2021

      8.3.1. Germany

      8.3.2. France

      8.3.3. U.K.

      8.3.4. Spain

      8.3.5. Italy

      8.3.6. Rest of Western Europe

   8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      8.5.1. Self-Injectors

      8.5.2. Needle free Injectors

         8.5.2.1. Pre Filled Needle free injectors

         8.5.2.2. Fill-Able Needle Free Injectors

      8.5.3. Auto Injectors

   8.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   8.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      8.7.1. Disposable Injectors

      8.7.2. Reusable Injectors

   8.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      8.9.1. Retail Pharmacies

      8.9.2. Hospital pharmacies

      8.9.3. E-Commerce

   8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   8.11. Drivers and Restraints: Impact Analysis

   8.12. Market Attractiveness Analysis

      8.12.1. By Country

      8.12.2. By Product

      8.12.3. By Usage

      8.12.4. By Distribution Channel

   8.13. Drivers and Restraints – Impact Analysis

9. Western Europe Market Analysis 2014–2021 and Forecast 2022–2028

   9.1. Introduction

   9.2. Regional Market Trends

   9.3. Historical Market Size (US$ Mn) By Country, 2014–2021

      9.3.1. Russia

      9.3.2. Poland

      9.3.3. Rest of Eastern Europe

   9.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      9.5.1. Self-Injectors

      9.5.2. Needle free Injectors

         9.5.2.1. Pre Filled Needle free injectors

         9.5.2.2. Fill-Able Needle Free Injectors

      9.5.3. Auto Injectors

   9.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   9.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      9.7.1. Disposable Injectors

      9.7.2. Reusable Injectors

   9.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      9.9.1. Retail Pharmacies

      9.9.2. Hospital pharmacies

      9.9.3. E-Commerce

   9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   9.11. Drivers and Restraints: Impact Analysis

   9.12. Market Attractiveness Analysis

      9.12.1. By Country

      9.12.2. By Product

      9.12.3. By Usage

      9.12.4. By Distribution Channel

   9.13. Drivers and Restraints – Impact Analysis

10. Latin America Market Analysis 2014–2021 and Forecast 2022–2028

   10.1. Introduction

   10.2. Regional Market Trends

   10.3. Historical Market Size (US$ Mn) By Country, 2014–2021

      10.3.1. Brazil

      10.3.2. Mexico

      10.3.3. Rest of Latin America

   10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   10.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      10.5.1. Self-Injectors

      10.5.2. Needle free Injectors

         10.5.2.1. Pre Filled Needle free injectors

         10.5.2.2. Fill-Able Needle Free Injectors

      10.5.3. Auto Injectors

   10.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   10.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      10.7.1. Disposable Injectors

      10.7.2. Reusable Injectors

   10.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   10.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      10.9.1. Retail Pharmacies

      10.9.2. Hospital pharmacies

      10.9.3. E-Commerce

   10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   10.11. Drivers and Restraints: Impact Analysis

   10.12. Market Attractiveness Analysis

      10.12.1. By Country

      10.12.2. By Product

      10.12.3. By Usage

      10.12.4. By Distribution Channel

   10.13. Drivers and Restraints – Impact Analysis

11. Asia Pacific excluding Japan and China (APEJC) Market Analysis 2014–2021 and Forecast 2022–2028

   11.1. Introduction

   11.2. Regional Market Trends

   11.3. Historical Market Size (US$ Mn) By Country, 2014–2021

      11.3.1. India

      11.3.2. Australia and New Zealand

      11.3.3. China

      11.3.4. ASEAN

      11.3.5. Rest of APEJ

   11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      11.5.1. Self-Injectors

      11.5.2. Needle free Injectors

         11.5.2.1. Pre Filled Needle free injectors

         11.5.2.2. Fill-Able Needle Free Injectors

      11.5.3. Auto Injectors

   11.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   11.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      11.7.1. Disposable Injectors

      11.7.2. Reusable Injectors

   11.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      11.9.1. Retail Pharmacies

      11.9.2. Hospital pharmacies

      11.9.3. E-Commerce

   11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   11.11. Drivers and Restraints: Impact Analysis

   11.12. Market Attractiveness Analysis

      11.12.1. By Country

      11.12.2. By Product

      11.12.3. By Usage

      11.12.4. By Distribution Channel

   11.13. Drivers and Restraints – Impact Analysis

12. Japan Market Analysis 2014–2021 and Forecast 2022–2028

   12.1. Introduction

   12.2. Market Trends

   12.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      12.5.1. Self-Injectors

      12.5.2. Needle free Injectors

         12.5.2.1. Pre Filled Needle free injectors

         12.5.2.2. Fill-Able Needle Free Injectors

      12.5.3. Auto Injectors

   12.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   12.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      12.7.1. Disposable Injectors

      12.7.2. Reusable Injectors

   12.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   12.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      12.9.1. Retail Pharmacies

      12.9.2. Hospital pharmacies

      12.9.3. E-Commerce

   12.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   12.11. Drivers and Restraints: Impact Analysis

   12.12. Market Attractiveness Analysis

      12.12.1. By Product

      12.12.2. By Usage

      12.12.3. By Distribution Channel

   12.13. Drivers and Restraints – Impact Analysis

13. MEA Market Analysis 2014–2021 and Forecast 2022–2028

   13.1. Introduction

   13.2. Regional Market Trends

   13.3. Historical Market Size (US$ Mn) By Country, 2014–2021

      13.3.1. GCC Countries

      13.3.2. South Africa

      13.3.3. Rest of MEA

   13.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

   13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      13.5.1. Self-Injectors

      13.5.2. Needle free Injectors

         13.5.2.1. Pre Filled Needle free injectors

         13.5.2.2. Fill-Able Needle Free Injectors

      13.5.3. Auto Injectors

   13.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   13.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      13.7.1. Disposable Injectors

      13.7.2. Reusable Injectors

   13.8. Market Size (US$ Mn) Forecast By Usage Type, 2022–2028

   13.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      13.9.1. Retail Pharmacies

      13.9.2. Hospital pharmacies

      13.9.3. E-Commerce

   13.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   13.11. Drivers and Restraints: Impact Analysis

   13.12. Market Attractiveness Analysis

      13.12.1. By Country

      13.12.2. By Product

      13.12.3. By Usage

      13.12.4. By Distribution Channel

   13.13. Drivers and Restraints – Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

   16.1. Competition Dashboard

   16.2. Market Share & Structure Analysis

   16.3. Company Deep Dive

      16.3.1. Amgen Inc.

         16.3.1.1. Overview

         16.3.1.2. Product and Usage Portfolio

         16.3.1.3. Production Footprint

         16.3.1.4. Sales Footprint

         16.3.1.5. Channel Footprint

         16.3.1.6. Strategy

            16.3.1.6.1. Marketing Strategy

            16.3.1.6.2. Product Strategy

            16.3.1.6.3. Channel Strategy

      16.3.2. Antares Pharma Inc.

         16.3.2.1. Overview

         16.3.2.2. Product and Usage Portfolio

         16.3.2.3. Production Footprint

         16.3.2.4. Sales Footprint

         16.3.2.5. Channel Footprint

         16.3.2.6. Strategy

            16.3.2.6.1. Marketing Strategy

            16.3.2.6.2. Product Strategy

            16.3.2.6.3. Channel Strategy

      16.3.3. Becton, Dickinson and Company

         16.3.3.1. Overview

         16.3.3.2. Product and Usage Portfolio

         16.3.3.3. Production Footprint

         16.3.3.4. Sales Footprint

         16.3.3.5. Channel Footprint

         16.3.3.6. Strategy

            16.3.3.6.1. Marketing Strategy

            16.3.3.6.2. Product Strategy

            16.3.3.6.3. Channel Strategy

      16.3.4. Consort Medical Plc (Bespak)

         16.3.4.1. Overview

         16.3.4.2. Product and Usage Portfolio

         16.3.4.3. Production Footprint

         16.3.4.4. Sales Footprint

         16.3.4.5. Channel Footprint

         16.3.4.6. Strategy

            16.3.4.6.1. Marketing Strategy

            16.3.4.6.2. Product Strategy

            16.3.4.6.3. Channel Strategy

      16.3.5. Crossjet

         16.3.5.1. Overview

         16.3.5.2. Product and Usage Portfolio

         16.3.5.3. Production Footprint

         16.3.5.4. Sales Footprint

         16.3.5.5. Channel Footprint

         16.3.5.6. Strategy

            16.3.5.6.1. Marketing Strategy

            16.3.5.6.2. Product Strategy

            16.3.5.6.3. Channel Strategy

      16.3.6. Medtronic plc

      16.3.6. Overview

         16.3.6.2. Product and Usage Portfolio

         16.3.6.3. Production Footprint

         16.3.6.4. Sales Footprint

         16.3.6.5. Channel Footprint

         16.3.6.6. Strategy

            16.3.6.6.1. Marketing Strategy

            16.3.6.6.2. Product Strategy

            16.3.6.6.3. Channel Strategy

      16.3.7. Mylan N.V.

         16.3.7.1. Overview

         16.3.7.2. Product and Usage Portfolio

         16.3.7.3. Production Footprint

         16.3.7.4. Sales Footprint

         16.3.7.5. Channel Footprint

         16.3.7.6. Strategy

            16.3.7.6.1. Marketing Strategy

            16.3.7.6.2. Product Strategy

            16.3.7.6.3. Channel Strategy

      16.3.8. SHL Group

         16.3.8.1. Overview

         16.3.8.2. Product and Usage Portfolio

         16.3.8.3. Production Footprint

         16.3.8.4. Sales Footprint

         16.3.8.5. Channel Footprint

         16.3.8.6. Strategy

            16.3.8.6.1. Marketing Strategy

            16.3.8.6.2. Product Strategy

            16.3.8.6.3. Channel Strategy

      16.3.9. West Pharmaceutical Services

         16.3.9.1. Overview

         16.3.9.2. Product and Usage Portfolio

         16.3.9.3. Production Footprint

         16.3.9.4. Sales Footprint

         16.3.9.5. Channel Footprint

         16.3.9.6. Strategy

            16.3.9.6.1. Marketing Strategy

            16.3.9.6.2. Product Strategy

            16.3.9.6.3. Channel Strategy

      16.3.10. Ypsomed

         16.3.10.1. Overview

         16.3.10.2. Product and Usage Portfolio

         16.3.10.3. Production Footprint

         16.3.10.4. Sales Footprint

         16.3.10.5. Channel Footprint

         16.3.10.6. Strategy

            16.3.10.6.1. Marketing Strategy

            16.3.10.6.2. Product Strategy

            16.3.10.6.3. Channel Strategy

17. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Region

   17.1. Introduction / Key Findings

   17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2014–2021

      17.2.1. North America

      17.2.2. Western Europe

      17.2.3. Eastern Europe

      17.2.4. Latin America

      17.2.5. Asia Pacific excluding Japan

      17.2.6. Japan

      17.2.7. Middle East and Africa

   17.3. Market Size (US$ Mn) Forecast By Region, 2022–2028

   17.4.Market Attractiveness Analysis By Region

18. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Product

   18.1. Introduction

   18.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2014–2021

      18.2.1. Self-Injectors

      18.2.2. Needle-free Injectors

      18.2.3. Auto-Injectors

   18.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028

   18.4. Market Attractiveness Analysis By Product Type

19. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Usage

   19.1. Introduction

   19.2. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2014–2021

      19.2.1. Disposable Injectors

      19.2.2. Reusable Injectors

   19.3. Market Size (US$ Mn) Forecast By Usage, 2022–2028

   19.4. Market Attractiveness Analysis By Usage

20. Global Market Analysis 2014–2021 and Forecast 2022–2028, By Distribution Channel

   20.1. Introduction

   20.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2021

      20.2.1. Retail Pharmacies

      20.2.2. Hospital Pharmacies

      20.2.3. E-commerce

   20.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022–2028

   20.4. Market Attractiveness Analysis By Distribution Channel

21. Global Market Analysis 2014–2021 and Forecast 2022–2028

   21.1. Market Value Share Analysis

      21.1.1. By Country

      21.1.2. By Product

      21.1.3. By Usage

      21.1.5. By Distribution Channel

   21.2.Y-o-Y Growth Analysis

      21.2.1. By Country

      21.2.2. By Product

      21.2.3. By Usage

      21.2.5. By Distribution Channel

   21.3. Absolute $ Opportunity

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Manufacturers of Market

Table 02: Global Manufacturers of Market

Table 03: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 04: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 05: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 06: North America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 07: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 08: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 09: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 10: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 11: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 12: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 13: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 14: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 15: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 16: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 17: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 18: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 19: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 20: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 21: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 22: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 23: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 24: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 25: Japan Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 26: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Country

Table 27: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 28: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 29: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Table 30: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Region

Table 31: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Product Type

Table 32: MEA Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Usage

Table 33: Global Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Share by Product Type (2017A)

Figure 02: Global Market Share by Usage (2017A)

Figure 03: Global Market Share by Distribution Channel (2017A)

Figure 04: Global Market Share by Region (2017A)

Figure 05: Global Healthcare Expenditure in US$ Mn (2014–2020)

Figure 06: North America Market Size

Figure 07: North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 08: U.S. Market Size (US$ Mn) Analysis, 2014–2021

Figure 09: U.S. Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 10: Canada Market Size (US$ Mn) Analysis, 2014–2021

Figure 11: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 12: North America Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 13: North America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 14: North America Needle-free Injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 15: North America Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 16: North America Auto injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 17: North America Auto injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 18: North America Market Attractiveness Analysis, By Country

Figure 19: North America Market Attractiveness Analysis, By Product Type

Figure 20: North America Market Attractiveness Analysis, By Usage

Figure 21: North America Market Attractiveness Analysis, By Distribution Channel

Figure 22: Eastern Europe Market Size

Figure 23: Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 24: Russia Market Size (US$ Mn) Analysis, 2014–2021

Figure 25: Russia Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 26: Poland Market Size (US$ Mn) Analysis, 2014–2021

Figure 27: Poland Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 28: Rest of Eastern Europe Market Size (US$ Mn) Analysis, 2014–2021

Figure 29: Rest of Eastern Europe Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 30: Eastern Europe Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 31: Eastern Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 32: Eastern Europe Needle-free Injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 33: Eastern Europe Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 34: Eastern Europe Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 35: Eastern Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 36: Eastern Europe Market Attractiveness Analysis, By Country

Figure 37: Eastern Europe Market Attractiveness Analysis, By Product Type

Figure 38: Eastern Europe Market Attractiveness Analysis, By Usage

Figure 39: Eastern Europe Market Attractiveness Analysis, By Distribution Channel

Figure 40: Western Europe Market Size

Figure 41: Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 42: Germany Market Size (US$ Mn) Analysis, 2014–2021

Figure 43: Germany Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 44: U.K. Market Size (US$ Mn) Analysis, 2014–2021

Figure 45: U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 46: France Market Size (US$ Mn) Analysis, 2014–2021

Figure 47: France Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 48: Italy Market Size (US$ Mn) Analysis, 2014–2021

Figure 49: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 50: Spain Market Size (US$ Mn) Analysis, 2014–2021

Figure 51: Spain Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 52: Rest of Western Europe Market Size (US$ Mn) Analysis, 2014–2021

Figure 53: Rest of Western Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 54: Western Europe Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 55: Western Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 56: Western Europe Needle-free Market Size (US$ Mn) Analysis, 2014–2021

Figure 57: Western Europe Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 58: Western Europe Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 59: Western Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 60: Western Europe Market Attractiveness Analysis, By Country

Figure 61: Western Europe Market Attractiveness Analysis, By Product Type

Figure 62: Western Europe Market Attractiveness Analysis, By Usage

Figure 63: Western Europe Market Attractiveness Analysis, By Distribution Channel

Figure 64: Latin America Market Size

Figure 65: Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 66: Brazil Market Size (US$ Mn) Analysis, 2014–2021

Figure 67: Brazil Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 68: Mexico Market Size (US$ Mn) Analysis, 2014–2021

Figure 69: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 70: Rest of Latin America Market Size (US$ Mn) Analysis, 2014–2021

Figure 71: Rest of Latin America Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 72: Latin America Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 73: Latin America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 74: Latin America Needle-free Market Size (US$ Mn) Analysis, 2014–2021

Figure 75: Latin America Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 76: Latin America Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 77: Latin America Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 78: Latin America Market Attractiveness Analysis, By Country

Figure 79: Latin America Market Attractiveness Analysis, By Product Type

Figure 80: Latin America Market Attractiveness Analysis, By Usage

Figure 81: Latin America Market Attractiveness Analysis, By Distribution Channel

Figure 82: APEJ Market Size

Figure 83: APEJ Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 84: India Market Size (US$ Mn) Analysis, 2014–2021

Figure 85: India Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 86: Australia & New Zealand Market Size (US$ Mn) Analysis, 2014–2021

Figure 87: Australia & New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 88: China Market Size (US$ Mn) Analysis, 2014–2021

Figure 89: China Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 90: ASEAN Countries Market Size (US$ Mn) Analysis, 2014–2021

Figure 91: ASEAN Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 92: Rest of APEJ Market Size (US$ Mn) Analysis, 2014–2021

Figure 93: Rest of APEJ Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 94: APEJ Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 95: APEJ Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 96: APEJ Needle-free Market Size (US$ Mn) Analysis, 2014–2021

Figure 97: APEJ Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 98: APEJ Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 99: APEJ Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 100: APEJ Market Attractiveness Analysis, By Country

Figure 101: APEJ Market Attractiveness Analysis, By Product Type

Figure 102: APEJ Market Attractiveness Analysis, By Usage

Figure 103: APEJ Market Attractiveness Analysis, By Distribution Channel

Figure 104: Japan Market Size

Figure 105: Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 106: Japan Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 107: Japan Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 108: Japan Needle-free Market Size (US$ Mn) Analysis, 2014–2021

Figure 109: Japan Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 110: Japan Autoinjectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 111: Japan Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 112: Japan Market Attractiveness Analysis, By Product Type

Figure 113: Japan Market Attractiveness Analysis, By Usage

Figure 114: Japan Market Attractiveness Analysis, By Distribution Channel

Figure 115: MEA Market Size

Figure 116: MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2026

Figure 117: GCC Countries Market Size (US$ Mn) Analysis, 2014–2021

Figure 118: GCC Countries Ambulance Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 119: South Africa Market Size (US$ Mn) Analysis, 2014–2021

Figure 120: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 121: Rest of MEA Market Size (US$ Mn) Analysis, 2014–2021

Figure 122: Rest of MEA Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 123: MEA Self-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 124: MEA Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 125: MEA Needle-free Market Size (US$ Mn) Analysis, 2014–2021

Figure 126: MEA Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 127: MEA Auto-injectors Market Size (US$ Mn) Analysis, 2014–2021

Figure 128: MEA Auto-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 129: MEA Market Attractiveness Analysis, By Country

Figure 130: MEA Market Attractiveness Analysis, By Product Type

Figure 131: MEA Market Attractiveness Analysis, By Usage

Figure 132: MEA Market Attractiveness Analysis, By Distribution Channel

Figure 133: Global Market Attractiveness Analysis, By Region

Figure 134: Global Market Attractiveness Analysis, By Product Type

Figure 135: Global Market Attractiveness Analysis, By End User

Figure 136: Global Market Attractiveness Analysis, By Distribution Channel

Figure 137: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2014 - 2021

Figure 138: Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Figure 139: Global Market Absolute $ Opportunity, 2014–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Injectable Potassium Phosphate Market

Published : September 2021

Healthcare

Injectable Benzodiazepine Market

Published : June 2020

Healthcare

Connected Drug Delivery Devices Market

Published : December 2021

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Google translate

Injectable Drug Delivery Market